Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2021 Results Conference Call November 4, 2021 8:00 AM ET Company Participants Ian Karp - SVP, IR and Corporate Communications Dr. John Leonard - CEO Dr. David Lebwohl - Chief Medical Officer Dr. Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - CFO Conference Call Participants Maury Raycroft - Jefferies Joon Lee - Truist Securities Rick Bienkowski - SVB Leerink Xiaobin Gao - Barclays Luca Issi - RBC Liisa Bayko - Evercore ISI Yanan Zhu - Wells Fargo ...

Bill, living with transthyretin amyloidosis, and his wife, Maura o E Corporate Overview October 2021 THERAPE 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding our: ability to co ...

Call Start: 08:00 January 1, 0000 9:00 AM ET Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2021 Earnings Conference Call August 5, 2021 08:00 ET Company Participants Ian Karp - Senior Vice President of Investor Relations & Corporate Communications John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Joon Lee - Truist Securities Luca Issi - RBC ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2021 Results Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Lina Li - Director of Investor Relations John Leonard - President and Chief Executive Officer David Lebwohl - Executive Vice President and Chief Medical Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President and Chief Financial Officer Conference Call Participants Sonya Bhatia - Goldman Sachs Maury Raycroft - Jef ...

Bill, living with transthyretin amyloidosis, and his wife, Maura o real Corporate Overview February 2021 THERAPEU 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding our: being ab ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2020 Earnings Conference Call February 25, 2021 8:00 AM ET Company Participants Josh Rappaport - Investor Relations John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientist Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Rick Bienkowski - SVB Leerink Timur Ivannikov - Raymond James Joon Lee - Truist Securities Yanan Zhu - Wells Fargo Tashdid Hasan - ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President and Chief Executive Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President, Chief Financial Officer David Lebwohl - Executive Vice President and Chief Medical Officer Conference Call Participants Salveen Richter - Goldman Sachs Maury Raycroft - Jeffer ...

Intellia Therapeutics (NASDAQ:NTLA) Q2 2020 Earnings Conference Call August 5, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President, CEO & Director Laura Sepp-Lorenzino - EVP & Chief Scientific Officer Glenn Goddard - EVP & CFO Conference Call Participants Maurice Raycroft - Jefferies Xiaochuan Dai - Barclays Bank Madhu Kumar - Robert W. Baird & Co. Timur Ivannikov - Raymond James & Associates Jay Olson - Oppenheimer Operator Good morning. My name is Rachel, and I w ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2020 Earnings Conference Call May 7, 2020 8:00 AM ET Company Participants Lina Li - Associate Director of Investor Relations John Leonard - Chief Executive Officer Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - Chief Financial Officer Jos?? Rivera - General Counsel Conference Call Participants Timur Ivannikov - Raymond James Maury Raycroft - Jefferies Rick Bienkowski - SVB Leerink Madhu Kumar - R.W. Baird Tony Butler - ROTH Capital Jay Olson - Op ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President, CEO & Director Laura Sepp-Lorenzino - EVP & Chief Scientific Officer Glenn Goddard - EVP & CFO Conference Call Participants Maurice Raycroft - Jefferies David Allen - Barclays Mani Foroohar - SVB Leerink Madhu Kumar - Robert W. Baird & Co. Steven Seedhouse - Raymond James & Associates Max Smock - BTIG Silvan Tuerkcan - Oppenhe ...